702 Results

People

  1. Motzer
    Motzer
  2. Livingston
    Livingston
  3. Norton
    Norton
  4. Aghajanian
    Aghajanian
  5. Hudis
    Hudis
  6. Krown
    Krown
  7. Sepkowitz
    Sepkowitz
  8. O'Reilly
    O'Reilly
  9. Panageas
    Panageas
  10. Horwitz
    Horwitz

Groups

  1. Department of Medicine (450)
  2. Solid Tumor Oncology Division (259)
  3. Hematologic Malignancies, Division of (178)
  4. Center for Hematologic Malignancies (151)
  5. Surgery (92)
  6. Survivorship Research (88)
  7. Epidemiology and Biostatistics (73)
  8. GSK Faculty (73)
  9. Division of Subspecialty Medicine (65)
  10. Gastrointestinal Oncology Service (64)
  1. "fever"
Formats
  1. Journal Article (657)
  2. Review (23)
  3. Conference Paper (6)
  4. Research Letter (6)
  5. Guidelines (5)
  6. Editorial (4)
  7. Correspondence (1)
Groups
  1. Department of Medicine (450)
  2. Solid Tumor Oncology Division (259)
  3. Hematologic Malignancies, Division of (178)
  4. Center for Hematologic Malignancies (151)
  5. Surgery (92)
  6. Survivorship Research (88)

More Groups

People
  1. Robert Motzer (24)
  2. Larry Norton (20)
  3. Philip Livingston (19)
  4. Carol Aghajanian (17)
  5. Clifford Hudis (17)
  6. Kent Sepkowitz (17)

More People

Years
  1. 2025 (21)
  2. 2024 (42)
  3. 2023 (40)
  4. 2022 (22)
  5. 2021 (25)
  6. 2020 (44)

More Years

Publications
  1. Journal of Clinical Oncology (68)
  2. Clinical Cancer Research (33)
  3. Blood (22)
  4. Lancet Oncology (22)
  5. Cancer (21)
  6. New England Journal of Medicine (18)

More Publications

Publishers
  1. Elsevier Inc. (107)
  2. American Society of Clinical Oncology (70)
  3. Elsevier Science, Inc. (55)
  4. Springer (53)
  5. Nature Publishing Group (40)
  6. Wiley Blackwell (38)

More Publishers

Results (702)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of patients with hematologic malignancies and COVID-19: A report from the ASH Research Collaborative Data Hub
    Journal Article

    Wood, W. A.; Neuberg, D. S.; Colton Thompson, J.; Tallman, M. S.; Sekeres, M. A.; Sehn, L. H.; Anderson, K. C.; Goldberg, A. D.; Pennell, N. A.; Niemeyer, C. M.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Determining the recommended dose of pacritinib: Results from the PAC203 dose-finding trial in advanced myelofibrosis
    Journal Article

    Gerds, A. T.; Savona, M. R.; Scott, B. L.; Talpaz, M.; Egyed, M.; Harrison, C. N.; Yacoub, A.; Vannucchi, A.; Mead, A. J.; Kiladjian, J. J.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Tazemetostat for patients with relapsed or refractory follicular lymphoma: An open-label, single-arm, multicentre, phase 2 trial
    Journal Article

    Morschhauser, F.; Tilly, H.; Chaidos, A.; McKay, P.; Phillips, T.; Assouline, S.; Batlevi, C. L.; Campbell, P.; Ribrag, V.; Damaj, G. L.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Electronic patient-reported symptom monitoring in patients recovering from ambulatory minimally invasive gynecologic surgery: A prospective pilot study
    Journal Article

    Zivanovic, O.; Chen, L. Y.; Vickers, A.; Straubhar, A.; Baser, R.; Veith, M.; Aiken, N.; Carter, J.; Curran, K.; Simon, B.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Treatment of severe cutaneous adverse reaction with tocilizumab
    Research Letter

    Hibler, B. P.; Markova, A.
    British Journal of Dermatology (2020)

    Fulltext@MSK | Save
  • Comprehensive molecular genetic studies of Epstein-Barr virus-negative aggressive Natural killer-cell leukemia/lymphoma
    Journal Article

    Gao, J.; Zhang, Y.; Yaseen, N. R.; Fang, Y.; Lu, X.; Sukhanova, M.; Chen, Q.; Chen, Y. H.
    Human Pathology (2020)

    Fulltext@MSK | Save
  • Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma
    Journal Article

    Rowinsky, E. K.; Paner, A.; Berdeja, J. G.; Paba-Prada, C.; Venugopal, P.; Porkka, K.; Gullbo, J.; Linder, S.; Loskog, A.; Richardson, P. G.; more...
    Investigational New Drugs (2020)

    Fulltext@MSK | Save
  • Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG Oncology/Gynecologic Oncology Group study
    Journal Article

    Huh, W. K.; Brady, W. E.; Fracasso, P. M.; Dizon, D. S.; Powell, M. A.; Monk, B. J.; Leath, C. A. 3rd; Landrum, L. M.; Tanner, E. J.; Crane, E. K.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy of selpercatinib in RET fusion-positive non-small-cell lung cancer
    Journal Article

    Drilon, A.; Oxnard, G. R.; Tan, D. S. W.; Loong, H. H. F.; Johnson, M.; Gainor, J.; McCoach, C. E.; Gautschi, O.; Besse, B.; Cho, B. C.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • Guidelines for management of urgent symptoms in patients with cholangiocarcinoma and biliary stents or catheters using the modified RAND/UCLA Delphi process
    Guidelines

    Iyer, R. V.; Acquisto, S. G.; Bridgewater, J. A.; Choti, M. A.; Hong, T. S.; Kis, B.; Mead, P. A.; Parikh, N. D.; Roberts, L. R.; Roberts, R.; more...
    Cancers (2020)

    Fulltext@MSK | Save